Geron Corporation

Geron Corporation is a biotechnology company focused on developing therapies that can extend and improve the lives of cancer patients. The company's mission is to discover and develop first-in-class therapeutic products based on telomerase research and other proprietary technologies. Geron's primary focus is on developing imetelstat, a telomerase inhibitor, for multiple types of cancers. By targeting telomerase, Geron aims to disrupt cancer cell proliferation and induce cancer cell death. The company also pursues collaborations with academic institutions and industry partners to advance its research and development efforts. Geron Corporation is committed to advancing innovative therapies that address unmet medical needs in the field of oncology.